Download
s00262-019-02460-3.pdf 2,62MB
WeightNameValue
1000 Titel
  • Immune biological rationales for the design of combined radio- and immunotherapies
1000 Autor/in
  1. Hader, Michael |
  2. Frey, Benjamin |
  3. Fietkau, Rainer |
  4. Hecht, Markus |
  5. Gaipl, Udo |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-01-18
1000 Erschienen in
1000 Quellenangabe
  • 69(2):293-306
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00262-019-02460-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000501/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Cancer immunotherapies are promising treatments for many forms of cancer. Nevertheless, the response rates to, e.g., immune checkpoint inhibitors (ICI), are still in low double-digit percentage. This calls for further therapy optimization that should take into account combination of immunotherapies with classical tumor therapies such as radiotherapy. By designing multimodal approaches, immune modulatory properties of certain radiation schemes, additional immune modulation by immunotherapy with ICI and hyperthermia, as well as patient stratification based on genetic and immune constitutions have to be considered. In this context, both the tumor and its microenvironment including cells of the innate and adaptive immune system have to be viewed in synopsis. Knowledge of immune activation and immune suppression by radiation is the basis for well-elaborated addition of certain immunotherapies. In this review, the focus is set on additional immune stimulation by hyperthermia and restoration of an immune response by ICI. The impact of radiation dose and fractionation on immune modulation in multimodal settings has to be considered, as the dynamics of the immune response and the timing between radiotherapy and immunotherapy. Another big challenge is the patient stratification that should be based on matrices of biomarkers, taking into account genetics, proteomics, radiomics, and 'immunomics'. One key aim is to turn immunological 'cold' tumors into 'hot' tumors, and to eliminate barriers of immune-suppressed or immune-excluded tumors. Comprehensive knowledge of immune alterations induced by radiation and immunotherapy when being applied together should be utilized for patient-adapted treatment planning and testing of innovative tumor therapies within clinical trials.
1000 Sacherschließung
lokal Hyperthermia
lokal Tumor Microenvironment/radiation effects [MeSH]
lokal Tumor Microenvironment/drug effects [MeSH]
lokal Antineoplastic Agents, Immunological/pharmacology [MeSH]
lokal Immunity [MeSH]
lokal Immunotherapy [MeSH]
lokal Immunologic Factors/pharmacology [MeSH]
lokal Research Design [MeSH]
lokal Tumor Microenvironment/immunology [MeSH]
lokal Tumor microenvironment
lokal Personalized medicine
lokal Hyperthermia, Induced/methods [MeSH]
lokal Neoplasms/pathology [MeSH]
lokal Neoplasms/therapy [MeSH]
lokal Immunomodulation/radiation effects [MeSH]
lokal Biomarkers, Tumor [MeSH]
lokal Combined Modality Therapy [MeSH]
lokal Drug Design [MeSH]
lokal Immunomodulation/drug effects [MeSH]
lokal Humans [MeSH]
lokal Radioimmunotherapy
lokal Treatment Outcome [MeSH]
lokal Animals [MeSH]
lokal Immune checkpoint inhibitors
lokal Neoplasms/etiology [MeSH]
lokal Antineoplastic Agents, Immunological/therapeutic use [MeSH]
lokal CITIM 2019
lokal Focussed Research Review
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SGFkZXIsIE1pY2hhZWw=|https://frl.publisso.de/adhoc/uri/RnJleSwgQmVuamFtaW4=|https://frl.publisso.de/adhoc/uri/RmlldGthdSwgUmFpbmVy|https://frl.publisso.de/adhoc/uri/SGVjaHQsIE1hcmt1cw==|https://orcid.org/0000-0001-6375-5476
1000 Hinweis
  • DeepGreen-ID: 61b4fa067dd94596be298bf0aec2fc30 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6470320.rdf
1000 Erstellt am 2023-11-18T05:32:43.404+0100
1000 Erstellt von 322
1000 beschreibt frl:6470320
1000 Zuletzt bearbeitet 2023-12-01T11:33:23.467+0100
1000 Objekt bearb. Fri Dec 01 11:33:23 CET 2023
1000 Vgl. frl:6470320
1000 Oai Id
  1. oai:frl.publisso.de:frl:6470320 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source